Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

688139.SS

HOLDREMOVE

Qingdao Haier Biomedical Co.,Ltd · Healthcare · China · $1.5B · Avg Vol: $22M/d

56
StockRank
Q
63
V
29
M
53
P/E (TTM)
38.7x
ROE
4.7%
D/E
0.0x
Dividend %
1.2%
AI CONVICTION THESIS

Qingdao Haier Biomedical is a solid player in medical cold chain storage, but it lacks direct alignment with our core high-conviction macro themes, and domestic Chinese healthcare spending remains structurally constrained.

COMPANY DESCRIPTION

Qingdao Haier Biomedical Co., Ltd. designs and manufactures low-temperature storage equipment and IoT-based biosafety solutions for the life sciences sector. The company's competitive moat is established through its global leadership in ultra-low temperature storage technology integrated with proprietary IoT tracking systems. It operates as a dominant, vertically integrated biomedical cold chain provider in China with an expanding international footprint.

FINANCIAL SUMMARY (USD)

Year2022202320242025CAGR
Revenue423M337M338M344M-6.7%
EPS0.280.190.170.12-24.9%
Shares318M318M318M318M0.0%
Debt5M4M5M14M38.4%
Equity594M625M646M647M2.9%
Op CF93M37M43M40M-24.9%
Inv CF-37M37M-117M2M
Fin CF-30M-25M-34M-40M
Loading...
PRICE (1M)-16.0%
3.864.284.695.115.52May 8May 29Jun 18
SMA 50SMA 200
Close
$3.95
RSI (14)
19.4
52W High
$5.66
From 52W High
0.7%

SCORE BREAKDOWN

Quality
63
ROIC
5.7%59.1
ROE
4.7%55.2
GP/Assets
18.4%42.9
Op. Margin
11.6%69.2
FCF/Assets
1.6%56.2
Piotroski
83.4
Int. Cover
50.0x91.5
D/E Ratio
0.00x94.9
Current Ratio
2.57x47.1
Value
29
P/E (TTM)
38.7x27.9
EV/EBITDA
27.4x13.1
P/FCF
722.6x11.8
P/B
1.9x57.4
P/S
3.7x49.3
Div Yield
1.2%34.4
Momentum
53
52W High %
70%55.6
RS 6M
-25%49.2
SMA 50/200
0.97x55.4
EPS Rev 4W
N/A
EPS Rev 12W
N/A
EPS Improve
+173%84.8
Q Growth
-28%19.4

FUNDAMENTALS

Market Cap
$1.5B
P/E (Forward)
14.2x
Gross Margin
46.2%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 688139.SS are excluded.

TickerCompanyMkt CapStockRankSignal
688139.SSQingdao Haier Biomedical Co.,Ltd(you)$1.5B56HOLD
688351.SSShanghai MicroPort EP MedTech Co., Ltd.$1.7B49HOLD
300298.SZSinocare Inc.$1.3B48HOLD
300482.SZGuangzhou Wondfo Biotech Co.,Ltd$1.2B66BUY
301363.SZMeHow Innovative Ltd.$2.1B65HOLD
688161.SSShandong Weigao Orthopaedic Device Co., Ltd$1.6B39HOLD
688198.SSBeijing Balance Medical Technology Co.,Ltd.$1.7B39HOLD
688108.SSSino Medical Sciences Technology Inc.$1.4B36HOLD
600055.SSBeijing Wandong Medical Technology Co.,Ltd.$1.3B37HOLD
002223.SZJiangsu Yuyue Medical Equipment & Supply Co., Ltd.$3.9B54HOLD

Peer medians: ROE 4.8% · P/E 27.6x · Gross margin 53.1%

Qingdao Haier Biomedical Co.,Ltd (688139.SS) — Stock Score Summary

Qingdao Haier Biomedical Co.,Ltd (688139.SS) has a MoatMap StockRank of 56/100 based on Quality (63/100), Value (29/100), and Momentum (53/100) factor scores. The current signal is HOLD. Qingdao Haier Biomedical is a solid player in medical cold chain storage, but it lacks direct alignment with our core high-conviction macro themes, and domestic Chinese healthcare spending remains structurally constrained.

Qingdao Haier Biomedical Co., Ltd. designs and manufactures low-temperature storage equipment and IoT-based biosafety solutions for the life sciences sector. The company's competitive moat is established through its global leadership in ultra-low temperature storage technology integrated with proprietary IoT tracking systems. It operates as a dominant, vertically integrated biomedical cold chain provider in China with an expanding international footprint.

Key Financial Metrics

Price$3.95
Market Cap$1.5B
P/E (TTM)38.70
P/E (Forward)14.18
Price/Book1.90
Return on Equity4.7%
Return on Invested Capital5.7%
Debt/Equity0.31
Gross Margin46.2%
Operating Margin11.6%
Revenue Growth-5.4%
Dividend Yield1.2%
Free Cash Flow$2M

Qingdao Haier Biomedical Co.,Ltd operates in the Medical Devices industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Qingdao Haier Biomedical Co.,Ltd’s (688139.SS) StockRank?
MoatMap’s StockRank for Qingdao Haier Biomedical Co.,Ltd (688139.SS) is 56/100, with a Hold signal. It is a composite of Quality (63), Value (29), and Momentum (53) factor ranks across MoatMap’s 20,000+ stock universe.
Does Qingdao Haier Biomedical Co.,Ltd have an economic moat?
Qingdao Haier Biomedical Co.,Ltd (688139.SS) has a Quality factor score of 63/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Qingdao Haier Biomedical Co.,Ltd a buy, hold, or sell?
MoatMap’s current signal for Qingdao Haier Biomedical Co.,Ltd (688139.SS) is Hold, based on a StockRank of 56/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Qingdao Haier Biomedical Co.,Ltd in?
Qingdao Haier Biomedical Co.,Ltd (688139.SS) operates in the Healthcare sector, specifically the Medical Devices industry (China).